Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Niven Ralph. Officer active across 1 company, notably Aerovate Therapeutics, Inc.. In total, 19 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €43k. Activity tracked since 18 August 2022. The latest transaction was filed on 5 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Niven Ralph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
1,400 shares@ US$1.743.1% of flowCommon StockSEC:0001415889-24-002957:0
1,400 shares@ US$1.743.1% of flowCommon StockSEC:0001415889-24-000818:0
1,400 shares@ US$1.743.1% of flowCommon StockSEC:0001415889-23-015987:0
4,200 shares@ US$1.749.3% of flowCommon StockSEC:0001415889-23-015508:0
650 shares@ US$1.741.4% of flowCommon StockSEC:0001415889-23-010965:0
650 shares@ US$1.741.5% of flowCommon StockSEC:0001415889-23-009390:0
1,600 shares@ US$2.144.3% of flowCommon StockSEC:0001415889-23-007685:1
205 shares@ US$21.63485.6% of flowCommon StockSEC:0001415889-23-007685:3
650 shares@ US$1.741.4% of flowCommon StockSEC:0001415889-23-007685:0
2,045 shares@ US$20.79353.5% of flowCommon StockSEC:0001415889-23-007685:2
650 shares@ US$1.741.4% of flowCommon StockSEC:0001415889-23-006376:0
650 shares@ US$1.741.5% of flowCommon StockSEC:0001415889-23-004512:0
650 shares@ US$1.741.5% of flowCommon StockSEC:0001415889-23-002169:0
650 shares@ US$1.741.5% of flowCommon StockSEC:0001415889-23-000708:0
650 shares@ US$1.741.5% of flowCommon StockSEC:0001415889-22-012183:0
650 shares@ US$1.741.6% of flowCommon StockSEC:0001415889-22-011246:0
650 shares@ US$1.741.6% of flowCommon StockSEC:0001415889-22-010412:0
650 shares@ US$1.741.6% of flowCommon StockSEC:0001493152-22-025289:0
650 shares@ US$1.741.6% of flowCommon StockSEC:0001493152-22-023617:0
About Niven Ralph
NIVEN RALPH is CHIEF SCIENTIFIC OFFICER at Aerovate Therapeutics, Inc. He has made 19 filings in total, and among the recent sampled filings, the period runs from 2022-08-19 to 2024-02-07, with EUR 0 in purchases and EUR 42599 in sales. The most common transaction nature is Exercise of options.